drugset / Trial / NCT00411541

Summary

Studies in the 1970s and 1980s suggested that the outcome of childhood acute lymphoblastic leukemia could be improved by intensification of conventional continuation chemotherapy with pulses of vincristine sulfate and steroids. We aimed to investigate the efficacy and toxic effects of vincristine-dexamethasone pulses as an addition to the continuation-therapy phase in a large cohort of children with intermediate-risk disease who were treated with the BFM treatment strategy

Timeline

Start
1995-04
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 6 mg/m2
Subject Vincristine Small molecule 1.5 mg/m2